Sentence examples for to further benefit from inspiring English sources
A recent Observer poll found just over half the public are opposed to further benefit cuts.
Mr. Kejriwal alleges this was done to further benefit the company.
Marc Hassinger, a BMW spokesman in Munich, said that the company already had "very positive" sales in China and would hope to further benefit if an appreciation of the currency improved domestic purchasing power and made imported components less costly.
And some people in Cambodia are all too aware of the risks that could come along with a stock market, saying that it could act as a tool to further benefit the country's elite.
Seeking to further benefit from India's growing prominence in high-technology industries, Cisco Systems Inc., the leading maker of computer equipment for the Internet, said it would invest $150 million over the next two years to expand its Indian research and development operations in Bangalore, making them Cisco's largest outside of the United States.
West Ham added in a later statement: "The worldwide draw of hosting the most popular and watched football league in the world in such an iconic venue will add value to any sponsorship and commercial agreements related to the stadium, which the public purse stands to further benefit from.
Ealing's McLester points to further benefits, including collaborative procurement and free services for suppliers.
On top of this, its commitment to further benefits cuts will likely have a disastrous effect on already vulnerable, marginalised and excluded sections of the student population, such as migrants and disabled students.
Matt Smith, president of hosted archiving provider LiveOffice, points to further benefits of hosted solutions: "A particular benefit for SMBs is that they're on the same infrastructure as a large enterprise an enterprise-class server," he says.
In addition, combining cancer immunotherapy with established treatment modalities, e.g., chemotherapy or radiotherapy, is also a viable strategy to provide further benefit to already impressive efficacy.
It also demonstrated that increasing canakinumab doses to >150 mg are unlikely to provide further benefit in RA clinical outcomes.
